Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Positive initial phase II data for nomacopan in bullous pemphigoid

April 24, 2019

Identification of selective, orally active RORgammat inverse agonists

April 24, 2019

Skin microbiome study gives insights into wound healing

April 23, 2019

Otsuka Pharmaceutical initiates two phase III studies of OPA-15406 ointment

April 17, 2019

Phase I/IIa trial of antibody-inducing peptide FPP-003 begins in Australia

April 17, 2019

Positive 12-month data presented from phase II study of Clascoterone

April 16, 2019

Mallinckrodt, Washington University to jointly search for drugs targeting chronic itch

April 12, 2019

Mechanism underlying youthful and aging skin found in mice

April 10, 2019

New phase I trial explores use of UB-221 for chronic spontaneous urticaria

April 5, 2019

Targeting hair loss outside the follicle

April 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...